Ünal Ç, Özmen T, İlgün AS, Ordu Ç, Özkurt E, Ak N, Alço G, Erdoğan İyigün Z, Kurt S, Duymaz T, Öztürk MA, Elbüken Çelebi F, Yararbaş K, Soybir G, Aktepe F, Özmen V

Breast Cancer: Targets and Therapy 2023, 15:659-669

Published Date: 1 September 2023

Review

Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer

Tong L, Yu X, Wang S, Chen L, Wu Y

Breast Cancer: Targets and Therapy 2023, 15:647-658

Published Date: 24 August 2023

Original Research

Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan

Haque R, Chen LH, Oestreicher N, Lalla D, Chlebowski RT

Breast Cancer: Targets and Therapy 2023, 15:637-645

Published Date: 16 August 2023

Original Research

ABVS-Based Radiomics for Early Predicting the Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancers

Jiang W, Deng X, Zhu T, Fang J, Li J

Breast Cancer: Targets and Therapy 2023, 15:625-636

Published Date: 15 August 2023

Original Research

Diagnostic Value of a Combined Serum α-Hydroxybutyrate Dehydrogenase, Carcinoembryonic Antigen and Glycoantigen 125 Test for Early-Stage Breast Cancer

Zhan CH, Liu GJ

Breast Cancer: Targets and Therapy 2023, 15:617-623

Published Date: 15 August 2023

Review

HER2-Low Breast Cancer: Current Landscape and Future Prospects

Shirman Y, Lubovsky S, Shai A

Breast Cancer: Targets and Therapy 2023, 15:605-616

Published Date: 14 August 2023

Original Research

Predictive miRNAs Patterns in Blood of Breast Cancer Patients Demonstrating Resistance Towards Neoadjuvant Chemotherapy

Fan J, Tang Y, Wang K, Yang S, Ma B

Breast Cancer: Targets and Therapy 2023, 15:591-604

Published Date: 11 August 2023

Original Research

Popularity of Traditional Chinese Medicine Use Among Breast Cancer Patients in North China: A Cross-Sectional Study

Zhao R, Zhang J, Gou Q, Gao J

Breast Cancer: Targets and Therapy 2023, 15:577-589

Published Date: 10 August 2023

Original Research

Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing

Bai Q, Lv H, Bao L, Yang Y, Zhang X, Chang H, Xue T, Ren M, Zhu X, Zhou X, Yang W

Breast Cancer: Targets and Therapy 2023, 15:563-575

Published Date: 3 August 2023

Original Research

Clinicopathological Risk Factors of Unfavorable Outcomes in Vietnamese Women with Primary Invasive Breast Cancer: A Retrospective Cohort Study

Huynh CG, Huynh NX, Truong BHT, Thai TT, Doan PTT

Breast Cancer: Targets and Therapy 2023, 15:551-561

Published Date: 1 August 2023

Letter

Early but Quality Diagnosis: On Breast Cancer and Its Risk Factors [Letter]

Zehra SS, Turabee Z, Rawalia MA

Breast Cancer: Targets and Therapy 2023, 15:549-550

Published Date: 1 August 2023

Original Research

Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib

Sharaf B, Abu-Fares H, Tamimi F, Al-Sawajneh S, Salama O, Daoud R, Alhajahjeh A, Al-Lababidi S, Abdel-Razeq H

Breast Cancer: Targets and Therapy 2023, 15:541-548

Published Date: 28 July 2023

Review

“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”

Höller A, Nguyen-Sträuli BD, Frauchiger-Heuer H, Ring A

Breast Cancer: Targets and Therapy 2023, 15:525-540

Published Date: 28 July 2023

Original Research

Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression

Purwanto I, Leo B, Hutajulu SH, Kurnianda J, Taroeno-Hariadi KW, Hardianti MS, Satiti AD, Dwianingsih EK, Heriyanto DS, Widodo I, Aryandono T

Breast Cancer: Targets and Therapy 2023, 15:515-524

Published Date: 27 July 2023

Original Research

Perceived Barriers and Facilitators to Breast Cancer Screening Among Women in Saudi Arabia

AlAbdulKader A, Gari D, Al yousif G, Alghamdi A, AlKaltham S, AlDamigh F, AlEisawi Y, AlGhamdi A, Al-Hayek O, AlMudhi A

Breast Cancer: Targets and Therapy 2023, 15:505-513

Published Date: 25 July 2023

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery

Ni Y, Deng F, Yu S, Zhang J, Zhang X, Huang D, Zhou H

Breast Cancer: Targets and Therapy 2023, 15:495-504

Published Date: 25 July 2023

Original Research

PRO Hair Safe Study: The Patient’s Perspective on the Effects of Scalp Cooling on Hair Preservation

Brunner C, Egle D, Ritter M, Kofler R, Giesinger JM, Schneitter L, Sztankay M, Emmelheinz M, Abdel Azim S, Wieser V, Oberguggenberger A

Breast Cancer: Targets and Therapy 2023, 15:485-494

Published Date: 17 July 2023

Original Research

On Ultrasonographic Features of Mucinous Carcinoma with Micropapillary Pattern

Yang WS, Li Y, Gao Y

Breast Cancer: Targets and Therapy 2023, 15:473-483

Published Date: 17 July 2023

Original Research

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer

Huang Y, Guo Y, Xiao Q, Liang S, Yu Q, Qian L, Zhou J, Le J, Pei Y, Wang L, Chang C, Chen S, Zhou S

Breast Cancer: Targets and Therapy 2023, 15:461-472

Published Date: 11 July 2023

Original Research

A Cross-Sectional Evaluation of Knowledge About Breast Cancer and Perceived Barriers to the Uptake of Mammogram Screening Among Northern Saudi Women: A Population-Based Study

Alanazi MF, Thirunavukkarasu A, Alrowily M, Alaqel N, Alaqel A, Alruwaili M, Alazmi NNM, Alhassan O, Aljarallah MFM, Altaymani AM

Breast Cancer: Targets and Therapy 2023, 15:451-460

Published Date: 10 July 2023

Original Research

Promoter Methylation-Regulated Differentially Expressed Genes in Breast Cancer

Sindi S, Hamdi N, Hassan S, Ganash M, Alharbi M, Alburae N, Azhari S, Alkhayyat S, Linjawi A, Alkhatabi H, Elaimi A, Alrefaei G, Alsubhi N, Alrafiah A, Alhazmi S

Breast Cancer: Targets and Therapy 2023, 15:435-450

Published Date: 6 July 2023

Case report

Pregnancy Associated Invasive Apocrine Carcinoma of the Breast: Case Report from Ethiopia

Alemu HK, Hammad N, Tola MA, Vanderpuye V

Breast Cancer: Targets and Therapy 2023, 15:429-433

Published Date: 23 June 2023

Original Research

Detecting the Frequency of c.5946delT Pathogenic Variant in the BRCA2 Gene and Associated Risk Factors Among Breast Cancer Patients Visiting Felege Hiwot Referral Hospital and University of Gondar Comprehensive Specialized Hospital

Berhane N, Chekol Z, Seid A

Breast Cancer: Targets and Therapy 2023, 15:421-427

Published Date: 19 June 2023

Original Research

Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis

Liu Y, Tang J, Qiu X, Teng LA, Sriwastva MK, Han X, Li Z, Liu M, Liu S, Da D, Li Z, Zhen L, Ren Y

Breast Cancer: Targets and Therapy 2023, 15:403-419

Published Date: 30 May 2023

Original Research

Transcriptome Profiling Analysis of Breast Cancer Cell MCF-7 Treated by Sesamol

Wu J, Luo D, Xu J

Breast Cancer: Targets and Therapy 2023, 15:391-401

Published Date: 29 May 2023

Original Research

Radiomics Analysis of Breast Lesions in Combination with Coronal Plane of ABVS and Strain Elastography

Ma Q, Shen C, Gao Y, Duan Y, Li W, Lu G, Qin X, Zhang C, Wang J

Breast Cancer: Targets and Therapy 2023, 15:381-390

Published Date: 26 May 2023

Review

ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion

Ahmad SMS, Nazar H, Rahman MM, Rusyniak RS, Ouhtit A

Breast Cancer: Targets and Therapy 2023, 15:373-380

Published Date: 24 May 2023

Original Research

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?

Dubrava AL, Kyaw PSP, Newman J, Pringle J, Westhuyzen J, La Hera Fuentes G, Shakespeare TP, Sakalkale R, Aherne NJ

Breast Cancer: Targets and Therapy 2023, 15:359-371

Published Date: 11 May 2023

Review

Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review

Alghamdi MAA, Esam Mahmood S

Breast Cancer: Targets and Therapy 2023, 15:349-358

Published Date: 9 May 2023

Original Research

Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications

da Silva JL, Carvalho GDS, Zanetti de Albuquerque L, Rodrigues FR, Fernandes PV, Kischinhevsky D, de Melo AC

Breast Cancer: Targets and Therapy 2023, 15:337-347

Published Date: 8 May 2023

Original Research

Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses

Jin Y, Lan A, Dai Y, Jiang L, Liu S

Breast Cancer: Targets and Therapy 2023, 15:327-335

Published Date: 1 May 2023

Original Research

Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study

Mery B, Ménétrier-Caux C, Montané L, Heudel PE, Ray-Coquard I, Bachelot T, Derbel O, Augereau P, Treilleux I, Berthet J, Nkodia A, Bardin-Dit-Courageot C, Attignon V, Ferrari A, Garin G, Perol D, Caux C, Dubois B, Trédan O

Breast Cancer: Targets and Therapy 2023, 15:311-325

Published Date: 27 April 2023

Original Research

Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients

Shen J, Yan H, Yang C, Lin H, Li F, Zhou J

Breast Cancer: Targets and Therapy 2023, 15:295-310

Published Date: 25 April 2023

Review

Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review

Wang J, Liao D, Zhang X, Miao C, Chen K

Breast Cancer: Targets and Therapy 2023, 15:281-294

Published Date: 21 April 2023

Original Research

Breast Cancer Awareness Among Medical Students, University of Bisha, Saudi Arabia

Miskeen E, Al-Shahrani AM

Breast Cancer: Targets and Therapy 2023, 15:271-279

Published Date: 17 April 2023

Original Research

Psychosocial Problems of Rural Indian Women Practising Breast Self-Examination – a Community-Based Study from Southern India

Balaiah Mehanathan P, Arthur Edwards Dennison A, Vikramathithan Panchapooranam A, Kandasamy S, Subbiah P, Velappan L, Kalyanaraman S

Breast Cancer: Targets and Therapy 2023, 15:263-270

Published Date: 17 April 2023

Original Research

Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study

Koo DH, Lee KS, Sim SH, Chae H, Lee EG, Han JH, Jung SY, Lee S, Kang HS, Lee ES, Park CY, Oh SW

Breast Cancer: Targets and Therapy 2023, 15:251-261

Published Date: 14 April 2023

Original Research

Clinicopathological Features and Survival Outcomes of Metaplastic Breast Carcinoma – An Observational Multi-Centric Study

Sherwani M, Vohra L, Ali D, Soomro R, Adnan S, Idrees R

Breast Cancer: Targets and Therapy 2023, 15:237-250

Published Date: 27 March 2023

Review

Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk

Satish S, Moore JF, Littlefield JM, Bishop IJ, Rojas KE

Breast Cancer: Targets and Therapy 2023, 15:227-235

Published Date: 22 March 2023

Original Research

Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis

Huo Q, Ning L, Xie N

Breast Cancer: Targets and Therapy 2023, 15:213-226

Published Date: 10 March 2023

Review

Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer

Castellanos G, Valbuena DS, Pérez E, Villegas VE, Rondón-Lagos M

Breast Cancer: Targets and Therapy 2023, 15:189-211

Published Date: 9 March 2023

Original Research

Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis

Cao Q, Ai XQ, Mushajiang M

Breast Cancer: Targets and Therapy 2023, 15:175-188

Published Date: 9 March 2023

Original Research

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?

Emiroglu S, Özkurt E, Cabıoglu N, Igci A, Saip P, Yazici H, Ozmen T, Ozmen V, Muslumanoglu M, Tukenmez M

Breast Cancer: Targets and Therapy 2023, 15:163-173

Published Date: 21 February 2023

Original Research

Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?

Jongbloed EM, Blommestein HM, van Schoubroeck HM, Martens JW, Wilting SM, Uyl-de Groot CA, Jager A

Breast Cancer: Targets and Therapy 2023, 15:147-161

Published Date: 16 February 2023

Original Research

The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis

Liao Y, Liao Y, Li J, Li Y, Fan Y

Breast Cancer: Targets and Therapy 2023, 15:135-146

Published Date: 11 February 2023

Response to Letter

Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Response to Letter]

AlSumai TS, Alhefdhi A

Breast Cancer: Targets and Therapy 2023, 15:133-134

Published Date: 6 February 2023

Original Research

Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in Breast Cancer

Li N, Song C, Huang X, Zhang H, Su J, Yang L, He J, Cui G

Breast Cancer: Targets and Therapy 2023, 15:121-132

Published Date: 5 February 2023

Original Research

An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC

Zhang M, Bao S, Qiu G, Liang J, Wang Q, Zhu X, Qin G, Liu J, Zhao C

Breast Cancer: Targets and Therapy 2023, 15:101-119

Published Date: 3 February 2023

Original Research

Assessment of Knowledge and Awareness About Breast Self-Examination Among University Female Students in Saudi Arabia

Albeshan S, Shubayr N, Alashban Y

Breast Cancer: Targets and Therapy 2023, 15:91-99

Published Date: 1 February 2023

Review

Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications

Prodhan ASU, Islam DZ, Khandker SS, Jamiruddin MR, Abdullah A, Godman B, Opanga S, Kumar S, Sharma P, Adnan N, Pisana A, Haque M

Breast Cancer: Targets and Therapy 2023, 15:51-89

Published Date: 27 January 2023

Case report

Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review

Badran O, Abu Amna M, Turgeman I, Bar-Sela G

Breast Cancer: Targets and Therapy 2023, 15:47-50

Published Date: 24 January 2023

Case report

Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review

Wu J, Jin Y, Liu M, Zhu N, Jing Z, Zeng X

Breast Cancer: Targets and Therapy 2023, 15:39-45

Published Date: 19 January 2023

Original Research

Critical Evaluation of Secondary Cancer Risk After Breast Radiation Therapy with Hybrid Radiotherapy Techniques

Zhang Q, Zeng Y, Peng Y, Yu H, Zhang S, Wu S

Breast Cancer: Targets and Therapy 2023, 15:25-38

Published Date: 23 January 2023

Original Research

Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins

Ma J, Dong C, Cao YZ, Ma BL

Breast Cancer: Targets and Therapy 2023, 15:11-24

Published Date: 17 January 2023

Original Research

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer

Abdel-Razeq H, Abujamous L, Al-Azzam K, Abu-Fares H, Bani Hani H, Alkyam M, Sharaf B, Elemian S, Tamimi F, Abuhijla F, Edaily S, Salama O, Abdulelah H, Daoud R, Abubaker M, Al-Atary A

Breast Cancer: Targets and Therapy 2023, 15:1-10

Published Date: 13 January 2023